Wang et al. demonstrated that impaired TRF2 function in vascular smooth muscle cells (VSMC) of genetically modified mice increases atherosclerosis and necrotic core formation, whereas overexpression of functional TRF2 protects against atherosclerosis independent of secretion of senescence-associated cytokines [77]. The gene discussed is TERF2; the disease is atherosclerosis.